Biden administration advances $1 billion arms sale to Israel amid ongoing Gaza conflict

As the U.S. prepares to ship another billion dollars’ worth of arms to Israel, progressive voices question the alignment with international humanitarian standards and the potential impacts on Palestinian civilian areas.

Image Credit: AFP

The Biden administration has signaled to Congress its intent to move forward with a substantial $1 billion arms sale to Israel. This development comes amidst heightened scrutiny over the potential use of these weapons in densely populated areas in Gaza. The decision marks a significant moment in U.S. foreign policy, reflecting a complex interplay of national security priorities, international diplomacy, and human rights advocacy.

The proposed package includes $700 million worth of tank ammunition, $500 million in tactical vehicles, and $60 million in mortar rounds. This disclosure was made to Congress earlier this week, signaling an initial step in a process that could see these weapons delivered over the coming years. Notably, this arms sale is one of the first major agreements under the Biden administration following a temporary halt on a previous weapons transfer, which included 3,500 bombs intended for use by Israel.

The arms deal has elicited a range of responses from U.S. lawmakers. Some of President Biden’s fellow Democrats have expressed reservations about continuing to supply offensive weaponry to Israel. Their concerns are primarily focused on the potential for these arms to be used in ways that could lead to civilian casualties in conflict zones like Gaza.

Conversely, Republican representatives have criticized the administration’s pause on previous arms transfers, arguing that it undermines Israel’s security needs. The GOP’s stance is reflected in the House’s current moves to mandate the delivery of such weaponry through new legislation. Despite opposition from the White House, which has threatened a veto, the debate underscores a deep partisan divide on U.S. military support for Israel.

This arms transaction is poised to reinforce the longstanding alliance between the U.S. and Israel. By furnishing Israel with enhanced military capabilities, the U.S. reaffirms its commitment to the security of its key ally in the Middle East. This support comes at a critical time as Israel continues its military operations against Hamas in Gaza.

Amid these developments, human rights organizations have voiced alarm over the implications of continued arms sales to Israel, especially given the ongoing military actions in Gaza. Reports from groups such as Amnesty International have criticized the U.S. and other countries for their role in facilitating what they view as violations of international humanitarian law. These critiques are bolstered by concerns that U.S.-supplied weapons have been used in heavy bombardments that disproportionately affect Palestinian civilians.

The decision has also sparked reactions beyond governmental circles. Protests on U.S. college campuses and advocacy by economic justice groups highlight a growing unease among the American public regarding the ethical dimensions of arms sales to conflict regions. Internationally, the response has been similarly contentious, with calls from global hum.

As detailed in notifications to Congress, the sale includes $700 million for tank ammunition, $500 million for tactical vehicles, and $60 million for mortar rounds. These figures reflect a significant continuation of U.S. policy towards Israel, despite recent pauses in arms transfers over concerns about their use in Gaza.

John Kirby, a national security spokesman, succinctly expressed the administration’s stance: “President Biden is committed to ensuring that Israel has all of the military means it needs to defend itself against all threats, including from groups like Hamas. We are ensuring that our support matches our ally’s defense needs while considering the operational use of these weapons.”


If you liked this article, please donate $5 to keep NationofChange online through November.